Loading clinical trials...

User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study | Clinical Trials | Clareo Health

COMPLETED

User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study

NCT02384226•University of Colorado, Denver

View on ClinicalTrials.gov

Summary

Refine content and delivery of the mHealth delivered lifestyle intervention program through iterative testing with small groups of users who provide feedback through on-line asynchronous focus groups.

Detailed Description

Participants are asked to: * Use mobile app for 4 weeks * Receive support from the lifestyle coach * Provide weekly and ongoing feedback via an online asynchronous user group platform on usability, navigability, acceptability, and satisfaction.

Eligibility

Age

18 - 45 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Age 18-45
•Body Mass Index (BMI): 25 - 45 kg/m2
•Positive history of one or more of the following complications in most recent singleton pregnancy:
•1. Gestational diabetes mellitus
•2. Preeclampsia (high blood pressure and proteinuria diagnosed after 20 weeks gestation)
•3. Gestational hypertension (new hypertension diagnosed after 20 weeks without proteinuria)
•4. Pre-term delivery (32-37 weeks)
•5. Small for gestational age (\<10th percentile for gestational age)
•Able to communicate in English
•Access to and be willing to use a wi-fi enabled iPhone or iPod
+3 more criteria

Exclusion Criteria

•Personal history of Type 1 or 2 diabetes
•Personal history of breast cancer or any other type of cancer other than a basal cell skin cancer;
•Personal history of major chronic illness including cardiovascular disease (coronary artery disease, congestive heart failure, valvular heart disease, stroke, transient ischemic attack, or intermittent claudication), kidney disease, liver disease, venous or arterial thromboembolic disease, adrenal insufficiency, depression requiring hospitalization within the past 6 months, or non-pregnancy related illness requiring overnight hospitalization in the past 6 months;
•Underlying disease/treatment that might interfere with participation in/completion of the study (e.g. significant gastrointestinal conditions, major psychiatric disorders, and others at the discretion of the study clinician)

Locations (1)

University of Colorado Hospital

Aurora, Colorado, United States

Key Dates

Start Date

September 1, 2015

Primary Completion Date

September 1, 2020

Completion Date

September 1, 2020

Last Updated

March 25, 2022

Enrollment

ACTUAL participants

Conditions

Gestational Diabetes MellitusPreeclampsiaGestational HypertensionPre-term DeliveryDelivery of Small for Gestational Age (SGA) Baby

Prevention of Preeclampsia in Denmark: A National Implementation Study

NCT07485140

Preeclampsia (PE)

View study

RECRUITINGEARLY_PHASE1

Vascular Effects of High-Salt After Preeclampsia

NCT06749418

PreeclampsiaPreeclampsia Postpartum

View study

RECRUITINGNA

Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 25, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study

Inclusion Criteria

Exclusion Criteria

Prevention of Preeclampsia in Denmark: A National Implementation Study

Vascular Effects of High-Salt After Preeclampsia

Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy

The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes